Memorial Göztepe Hospital
Dr. Zulfikar Polat is a professor of gastroenterology at Istanbul Aydın University. He previously practiced at Anadolu Medical Center, an affiliate of Johns Hopkins Medicine. Dr. Polat focuses on hepato-pancreatology and inflammatory intestinal diseases. He serves as an expert in both diagnostic and interventional endoscopic procedures.
Prof. Dr. İbrahim Doğan is a gastroenterologist. He earned his MD from Ankara University Faculty of Medicine in 1991. He became an Internal Medicine specialist at Gazi University in 1996. He completed gastroenterology subspecialty training at İnönü University in 2001.
His academic career was at Gazi University. He served as Lecturer (2002), Assistant Professor (2003), Associate Professor (2007), and Professor (2012). He worked as a researcher at the University of California San Diego from 2004 to 2006. He has practiced at Koru Hospital since January 2023.
Clinical focus includes gastroesophageal reflux, irritable bowel syndrome, constipation, gastroparesis, achalasia, bloating, gas and belching, fecal incontinence, ulcerative colitis, and Crohn’s disease. He performs ERCP, stent placement, balloon and bougie dilation, polypectomy, argon plasma coagulation, double-balloon enteroscopy, and bleeding control.
Prof. Dr. Musa Aydınlı is an internal medicine specialist and gastroenterologist. He completed his MD at Hacettepe University in 1997. He finished internal medicine training in 2003 and gastroenterology training in 2007 at the same institution. He worked at Kayseri Training and Research Hospital from 2007 to 2009. He served in the Gastroenterology Department at Gaziantep University from 2009 to 2014. He became an associate professor in 2012 and a professor in 2020. He joined Gülhane Training and Research Hospital in 2022. He now practices at Private Koru Ankara Hospital.
Clinical focus: GERD; dyspepsia, gastritis, and Helicobacter pylori; peptic ulcer disease; celiac disease; IBS and IBD (ulcerative colitis, Crohn’s disease); colon polyps; colorectal and upper GI cancers; liver disease (fatty liver, chronic hepatitis, cirrhosis, portal hypertension); hepatobiliary and pancreatic disorders and cancers. Procedures: EGD, rectosigmoidoscopy, and colonoscopy; biopsy, polypectomy, and endoscopic mucosal resection; hemostasis and APC; dilation and stent placement; PEG; ERCP; EUS-guided biopsy.
Dr. Suleyman Guray is a gastroenterologist at Memorial Göztepe Hospital in Istanbul. He specializes in endoscopy and internal medicine. He completed training in endoscopic interventions at CHA Bundang Medical Center. Dr. Guray belongs to the Turkish Society of Gastroenterology.
Turkish doctors treat toxic hepatitis by immediately removing the causative agent and stabilizing liver function. JCI-accredited facilities use therapeutic plasma exchange and advanced diagnostics to manage chemical-induced injury. Specialist hepatologists monitor liver regeneration or perform emergency transplants if acute failure occurs.
Bookimed Expert Insight: Success in treating toxic hepatitis depends on quick diagnostic precision. Dr. Zulfikar Polat at Anadolu Medical Center brings international expertise as a member of the American Association for the Study of Liver Diseases. His affiliation with Johns Hopkins Medicine ensures patients receive protocols based on the latest global hepatology research.
Turkey offers specialized liver care within multidisciplinary medical centers and JCI-accredited facilities. Specialized gastroenterology and hepatology departments treat toxic hepatitis using advanced imaging. Major centers like Liv Hospital Ulus and Anadolu Medical Center provide the ICU monitoring and transplantation services required for severe cases.
Bookimed Expert Insight: Our data suggests prioritizing hospitals with active transplant programs even for non-surgical toxicity cases. Centers like Liv Hospital Ulus, which performs 13,200 operations annually, maintain higher-level ICU capabilities. This ensures immediate intervention if drug-induced injury progresses rapidly toward liver failure.
Patient Consensus: Patients note that arriving with a complete medication list helps teams identify toxins faster. Many emphasize choosing large tertiary hospitals over small private clinics for 24-hour specialist availability.
Turkish centers report a 1-year survival rate exceeding 90% for liver failure treatment. Long-term outcomes for transplant patients range from 75% to 85% over five years. Specialized facilities like Liv Hospital Ulus maintain Joint Commission International accreditation for complex organ transplantation procedures.
Bookimed Expert Insight: High-volume centers like Liv Hospital Ulus perform over 13,200 operations annually. This volume correlates with technical proficiency in complex procedures. Patients should seek specialists like Prof. Dr. Zulfikar Polat, who is affiliated with Johns Hopkins Medicine. High institutional volume and international academic affiliations are the strongest indicators of procedural success.
Patient Consensus: Patients emphasize that stopping the toxin quickly is the most critical factor for recovery. Many advise focusing on the hospital's ability to manage emergency ICU care and transplant evaluations immediately.
Stay duration for toxic hepatitis treatment in Turkey typically ranges from 3 to 14 days. The timeline depends on liver enzyme stability and the severity of chemical or drug-induced injury. Turkish gastroenterology centers prioritize stabilizing liver function and confirming the removal of toxic triggers before clearance.
Bookimed Expert Insight: While many medical stays in Turkey are fixed durations, liver recovery is unpredictable. Professor Dr. Zulfikar Polat at Anadolu Medical Center emphasizes that return flights should only be confirmed after liver function tests trend downward. Data shows that 1–2 extra days for pre-flight bloodwork significantly reduces risks during long-haul travel.
Patient Consensus: Patients note that hospital stays are driven by lab results rather than fixed clinic schedules. They emphasize waiting until jaundice and nausea fully resolve before attempting to travel back home.
Liver transplants are available in Turkey for severe liver failure caused by toxic hepatitis. High-volume transplant centres in Istanbul and Ankara manage acute cases from toxins or medications. These facilities use living donor liver transplantation (LDLT) to provide rapid treatment when deceased donor organs are unavailable.
Bookimed Expert Insight: Gastroenterology specialists at Private Koru Ankara Hospital include Prof. Dr Ibrahim Dogan and Prof. Dr Musa Aydinli. They bring extensive international research experience. Data shows these centres integrate diagnostics like EUS and ERCP to manage biliary complications. This approach often helps stabilise toxic hepatitis patients before they need an emergency transplant.
Patient Consensus: Patients note that Turkish centres often accept complex cases but emphasise confirming donor eligibility before travel. Practical experience shows that having a related donor ready is essential for emergency approval in Turkey.
International patients choose Turkey for toxic hepatitis care to access rapid diagnostics and specialised hepatology expertise. Leading Turkish specialists hold memberships in the American Association for the Study of Liver Diseases. This means clinical protocols meet global standards. Private centres provide immediate consultations, bypassing long Australian waiting lists.
Bookimed Expert Insight: Turkish hepatology thrives on high-volume academic expertise, with professors often managing 45+ scientific publications alongside clinical practice. At centres like Private Koru Ankara Hospital, specialists such as Prof Dr Musa Aydinli combine internal medicine with gastroenterology subspecialties. This dual expertise is vital for toxic hepatitis cases, where systemic health often impacts liver recovery.
Patient Consensus: Patients value the speed of access for tests and imaging in Turkey when appointments are slow at home. They note that hospital stays feel organised and efficient, though they stress that follow-up blood tests must be manageable back in Australia.
Toxic hepatitis is liver inflammation caused by exposure to toxins, chemicals, or medications. Turkish clinics treat this by identifying the trigger. They perform rapid diagnostics like FibroScan and provide intensive supportive care. Highly credentialled specialists in Istanbul and Ankara lead these hepatology departments.
Bookimed Expert Insight: Turkish gastroenterology units offer a significant advantage for Australian patients through their multidisciplinary tumour boards. At Memorial Göztepe Hospital, these boards review complex liver cases. This guarantees a collaborative recovery plan, even for advanced injury.
Patient Consensus: Patients in Turkey report that diagnosis is often blood-led and exceptionally fast. They suggest bringing a full list of all supplements and medications to appointments. This helps doctors identify the toxin quickly.
Turkish specialists diagnose toxic hepatitis by confirming liver injury and ruling out viral or autoimmune causes. Standard pre-treatment tests include comprehensive liver function blood panels, abdominal ultrasounds, and viral serology. These results help doctors establish the injury pattern before starting specific reversal therapies.
Bookimed Expert Insight: Professor Zulfikar Polat practises at Anadolu Medical Center. Alongside other top Turkish hepatologists, he typically uses RUCAM causality tools with diagnostic tests. This systematic approach links your toxin exposure timeline directly to liver enzyme spikes. Clinics affiliated with major institutions, like Johns Hopkins Medicine, meet international diagnostic standards. Data shows this.
Patient Consensus: Patients note it is common to start with private liver blood panels. They do this in Turkey before their first appointment. They often undergo screening for hepatitis A, B, C, and E markers. This excludes viral infections while they await ultrasound results.